Taysha Gene Therapies, Inc. TSHA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets?
- Taysha Gene Therapies, Inc. (TSHA) reported operating lease right-of-use assets in other assets of $9.16M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets increased by 13.3% year-over-year, from $8.08M to $9.16M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating lease right-of-use assets in other assets has grown at a -4.8% compound annual growth rate (CAGR), from $10.94M to $9.44M.